Production (Stage)
Aligos Therapeutics, Inc.
ALGS
$5.50
-$0.17-3.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.28% | -58.04% | 6.38% | 4.07% | 8.91% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.36% | -3.31% | 16.28% | 47.84% | -9.94% |
| Total Current Assets | 21.29% | -55.95% | 6.94% | 5.65% | 7.89% |
|
|
|||||
| Total Current Assets | 21.29% | -55.95% | 6.94% | 5.65% | 7.89% |
| Net Property, Plant & Equipment | -25.52% | -25.38% | -24.72% | -23.56% | -21.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.12% | 0.32% | 1.93% | 1.12% | -1.11% |
| Total Assets | 17.82% | -53.74% | 3.00% | 2.53% | 5.06% |
|
|
|||||
| Total Accounts Payable | 56.93% | 2.15% | -6.83% | 110.40% | 0.71% |
| Total Accrued Expenses | -8.65% | -7.63% | 14.92% | -12.55% | -20.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.51% | 6.76% | 4.45% | 3.65% | 3.97% |
| Total Finance Division Other Current Liabilities | -- | -88.46% | -83.42% | -80.93% | -89.74% |
| Total Other Current Liabilities | -- | -88.46% | -83.42% | -80.93% | -89.74% |
| Total Current Liabilities | 0.36% | -9.07% | -6.73% | -13.45% | -32.76% |
|
|
|||||
| Total Current Liabilities | 0.36% | -9.07% | -6.73% | -13.45% | -32.76% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -39.16% | -37.75% | -32.69% | -29.37% | -18.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -74.01% | 161.97% | 25,206.52% | 12,304.30% | 45,077.42% |
| Total Liabilities | -49.70% | 66.65% | 23.52% | 13.94% | 84.13% |
|
|
|||||
| Common Stock & APIC | 18.92% | 1.77% | 14.06% | 14.38% | 14.74% |
| Retained Earnings | -10.21% | -26.95% | -16.77% | -17.18% | -23.59% |
| Treasury Stock & Other | -6.09% | -17.25% | 16.10% | -0.60% | -4.61% |
| Total Common Equity | 94.74% | -131.47% | -8.62% | -3.46% | -29.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 94.74% | -131.47% | -8.62% | -3.46% | -29.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 94.74% | -131.47% | -8.62% | -3.46% | -29.44% |
|
|
|||||